Patent · US Active

Method for the preparation of (3E,7E)-homofarnesic acid or (3E,7E)-homofarnesic acid ester

US11136611B2 · kind B2 · utility

0Cited by

6References

13Claims

0Family size

Assignee

BASF SE

Inventors

Wolfgang Siegel · Schifferstadt, DE
Melanie WEINGARTEN · Ludwigshafen am Rhein, DE
Michael Breuer · Darmstadt, DE
Mathias Schelwies · Ludwigshafen am Rhein, DE

Key dates

Filing date	Feb 23, 2018
Grant date	Oct 5, 2021
Priority date	—
Expiry date	Feb 23, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y504/99017
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention provides an improved method of isolating the 3-(E)-isomer of an unsaturated carboxylic acid from a mixture of corresponding (E/Z)isomers. More particularly, the present invention relates to an improved method for the biocatalytic preparation of (3E,7E)-homofarnesylic acid; as well as a novel biocatalytic method for the improved preparation of homofarnesol, in particular of (3E,7E)-homofarnesol and homofarnesol preparations having an increased content of (3E,7E)-homofarnesol. The present invention also relates to methods of preparing(−)-ambroxby applying (3E,7E)-homofarnesylic acid or (3E,7E)-homofarnesol as obtained according to the invention as starting material.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.